Oliver Pascal Gautschi
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 77
- Lung Cancer Diagnosis and Treatment 21
- Occupational and environmental lung diseases 11
- Oncology 62
- Cancer Immunotherapy and Biomarkers 17
- Colorectal Cancer Treatments and Studies 15
- Lung Cancer Research Studies 13
- Co-authors
- René Zellweger (15 shared papers)Nicolas Roydon Smoll (24 shared papers)Sönke Percy Frey (4 shared papers)Jim Heighway (6 shared papers)Martin Nikolaus Stienen (44 shared papers)Karl Schaller (23 shared papers)Dieter Cadosch (19 shared papers)Joachim Diebold (20 shared papers)
- Journals
- Journal of Thoracic Oncology (26 papers)Annals of Oncology (26 papers)Lung Cancer (17 papers)Clinical Lung Cancer (11 papers)Acta Neurochirurgica (10 papers)
- Partner nations
- SwitzerlandAustraliaUnited States
In The Last Decade
Oliver Pascal Gautschi
252 papers receiving 13.2k citations
Oliver Pascal Gautschi's Hit Papers
Peers
Comparison fields: 5 of 156
- Pulmonary and Respiratory Medicine 6.1k
- Oncology 4.7k
- Cancer Research 2.0k
- Pathology and Forensic Medicine 1.1k
- Molecular Biology 3.2k
Countries citing papers authored by Oliver Pascal Gautschi
This map shows the geographic impact of Oliver Pascal Gautschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Pascal Gautschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Pascal Gautschi more than expected).
Fields of papers citing papers by Oliver Pascal Gautschi
This network shows the impact of papers produced by Oliver Pascal Gautschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Pascal Gautschi. The network helps show where Oliver Pascal Gautschi may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Pascal Gautschi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 257 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry Hit paper breakdown → | 2019 | 1055 |
| 2 | Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2020 | 610 |
| 3 | Efficacy of Selpercatinib in RET -Altered Thyroid Cancers Hit paper breakdown → | 2020 | 589 |
| 4 | Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives Hit paper breakdown → | 2013 | 558 |
| 5 | Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2017 | 471 |
| 6 | 2007 | 343 | |
| 7 | 2017 | 337 | |
| 8 | 2008 | 329 | |
| 9 | Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort Hit paper breakdown → | 2015 | 306 |
| 10 | 2015 | 298 | |
| 11 | 2017 | 298 | |
| 12 | 2015 | 262 | |
| 13 | 2004 | 238 | |
| 14 | 2020 | 225 | |
| 15 | 2006 | 218 | |
| 16 | 2020 | 214 | |
| 17 | 2009 | 180 | |
| 18 | 2018 | 174 | |
| 19 | 2017 | 167 | |
| 20 | 2013 | 162 |
About Oliver Pascal Gautschi
Oliver Pascal Gautschi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine, Neurology and Surgery, having authored 257 papers that have together received 13.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (77 papers), Spine and Intervertebral Disc Pathology (26 papers), Lung Cancer Diagnosis and Treatment (21 papers), Cancer Immunotherapy and Biomarkers (17 papers), Colorectal Cancer Treatments and Studies (15 papers), Lung Cancer Research Studies (13 papers), Musculoskeletal pain and rehabilitation (12 papers) and Occupational and environmental lung diseases (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.1k citations), Oncology (4.7k citations), Cancer Research (2.0k citations), Pathology and Forensic Medicine (1.1k citations) and Molecular Biology (3.2k citations). Oliver Pascal Gautschi has collaborated with scholars based in Switzerland, Australia and United States. Frequent co-authors include René Zellweger, Nicolas Roydon Smoll, Sönke Percy Frey, Jim Heighway, Martin Nikolaus Stienen, Karl Schaller, Dieter Cadosch, Joachim Diebold, Daniel C. Betticher and Sacha I. Rothschild. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer, Clinical Lung Cancer and Acta Neurochirurgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.